Filing Flows › Comparisons › VRCA vs CELU
Verrica Pharmaceuticals vs Celularity: VRCA and CELU compared
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.4M for Celularity (Q2 2026). Celularity is growing faster (-5% against -54% a year earlier). Celularity is more profitable, with an operating margin of -78.0% against -223.4%.
Where the money goes: VRCA and CELU
Verrica Pharmaceuticals (VRCA) · Q2 2026
Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
Celularity (CELU) · Q2 2026
Celularity, Q2 2026: revenue $5.4M (-5% year over year), operating margin -78.0%, net earnings $706K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Verrica Pharmaceuticals (VRCA) | Celularity (CELU) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $5.9M | $5.4M |
| Revenue growth, Y/Y | -54% | -5% |
| Operating margin | -223.4% | -78.0% |
| Net earnings | −$13.2M | $706K |
| Net margin | -224.4% | 13.0% |
| Operating cash flow | −$9.3M | −$1.1M |
Where the revenue comes from
Celularity
- Product: $4.1M (75%)
- License Royalty and Other: $719K (13%)
- Service: $652K (12%)
Questions
Which is bigger, Verrica Pharmaceuticals or Celularity?
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.4M for Celularity (Q2 2026).
Is Verrica Pharmaceuticals or Celularity growing faster?
Celularity is growing faster (-5% against -54% a year earlier).
Which is more profitable, Verrica Pharmaceuticals or Celularity?
Celularity is more profitable, with an operating margin of -78.0% against -223.4%.
More: Verrica Pharmaceuticals earnings · how Verrica Pharmaceuticals makes money · Celularity earnings · how Celularity makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Oct 20, 2026). Fiscal quarters can end on different dates. Not investment advice.